Effect of Therapeutic Inertia on Treatment Outcomes in Type 2 Diabetes Patients at a Tertiary Care Hospital in Southern Ethiopia: A retrospective Cohort Study
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Aims
Therapeutic inertia is the failure to initiate or intensify treatment when clinically indicated, remains a major challenge to optimal glycemic control in patients with type 2 diabetes. This retrospective cohort study investigated the effect of therapeutic inertia on treatment outcomes in patients with type 2 diabetes receiving care at a tertiary hospital in southern Ethiopia.
Materials and methods
A retrospective cohort study was conducted among 159 adult ambulatory type 2 diabetic patients between June 2020-2023. We collected the data from medical records and we used EpiData version 4.6 for data entry and SPSS version 25 for analysis. The independent sample t-test, fisher’s exact test and chi-square test were used for data analysis as appropriate. To assess the effect of therapeutic inertia on diabetic treatment outcomes, we applied a cox proportional hazard model. A p-value of less than 0.05 was considered statistically significant.
Results
In this study, we reviewed the medical records of type 2 diabetic patients. Poor treatment outcomes were common in exposed to therapeutic inertia group (68.63%).There was a statistically significant difference between groups in the type of physician managing the patients (p=0.01).furthermore, the presence of comorbidity (p=0.024), mean fasting plasma glucose level (p=0.01), neuropathy(p=0.02) and nephropathy (p=0.011) showed a significant association with therapeutic inertia. Therapeutic inertia exposed group was significantly associated with increased the risk of poor treatment outcome with adjusted HR of 1.927 (95% CI: 1.201-3.092, p = 0.007).
Conclusions
Our study showed therapeutic inertia has worsened diabetic treatment outcomes among type 2 diabetes patients. This underlines the Healthcare providers should prioritize proactive management, such as regular reassessment of treatment efficacy and prompt adjustment of therapies, to improve patient outcomes.
